| 产品名称： | Escherichia coli (Migula) Castellani and Chalmers |
|---|---|
| 商品货号： | TS170914 |
| Classification： | Enterobacteriaceae, Escherichia |
| Strain Designations： | HA63 |
| Application： | protease-deficient transformation host |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Shipping Information： | Distributed: freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Genotype： | snoB lon |
| Type Strain： | no |
| Comments： | Phenotype verified: kanR, tetR. |
| Medium： | LB plus kanamycin (50 mcg/ml) plus tetracycline (15 mcg/ml)
|
| Growth Conditions： | Temperature: 37.0°C |
| Name of Depositor： | The General Hospital Corporation, FM Ausubel, The General Hospital Corporation |
| U.S. Patent Number： | |
| References： | Huala E, Ausubel FM. Protease deficient bacterial hosts. US Patent 5,143,846 dated Sep 1 1992 Huala E, et al. Aerobic inactivation of Rhizobium meliloti NifA in Escherichia coli is mediated by lon and two newly identified genes, snoB and snoC. J. Bacteriol. 173: 382-390, 1991. PubMed: 1846139 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Escherichia coli (Migula) Castellani and Chalmers |
|---|---|
| 商品货号： | TS170914 |
| Classification： | Enterobacteriaceae, Escherichia |
| Strain Designations： | HA63 |
| Application： | protease-deficient transformation host |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Shipping Information： | Distributed: freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Genotype： | snoB lon |
| Type Strain： | no |
| Comments： | Phenotype verified: kanR, tetR. |
| Medium： | LB plus kanamycin (50 mcg/ml) plus tetracycline (15 mcg/ml)
|
| Growth Conditions： | Temperature: 37.0°C |
| Name of Depositor： | The General Hospital Corporation, FM Ausubel, The General Hospital Corporation |
| U.S. Patent Number： | |
| References： | Huala E, Ausubel FM. Protease deficient bacterial hosts. US Patent 5,143,846 dated Sep 1 1992 Huala E, et al. Aerobic inactivation of Rhizobium meliloti NifA in Escherichia coli is mediated by lon and two newly identified genes, snoB and snoC. J. Bacteriol. 173: 382-390, 1991. PubMed: 1846139 |
